GlassScriptPhysician profile
Gail Bain-Markowski
NPI 1346301744
$2,041.99
in general payments reported to CMS, 2019-2025
16 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $127 · 2022: $319 · 2023: $596 · 2024: $483 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,595.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, INC. | $262.71 | 2022-2023 | |
| Grifols USA, LLC | $245.17 | 2024-2025 | Prolastin-C Liquid |
| Janssen Pharmaceuticals, INC | $141.30 | 2023 | Invega Sustenna |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $125.50 | 2021-2022 | |
| Mylan Specialty L.P. | $124.99 | 2024 | Yupelri |
| Alnylam Pharmaceuticals INC. | $124.99 | 2022 | |
| Abbvie INC. | $124.99 | 2023 | |
| Incyte Corporation | $124.99 | 2023 | Jakafi |
| Novo Nordisk INC | $124.99 | 2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.53 | 2025 | |
| Gilead Sciences, INC. | $119.99 | 2024 | Epclusa |
| Neurelis, INC. | $117.44 | 2024 | Valtoco |
| Teva Pharmaceuticals USA, INC. | $109.10 | 2025 | Uzedy |
| Nxstage Medical, INC. | $101.23 | 2022-2025 | Nxstage System One |
| Medtronic, INC. | $53.12 | 2021-2023 | Corevalve Evolut R |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $18.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gail Bain-Markowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.